Characteristic | Value (n = 163) |
---|---|
Hypermucoviscosity | 50 (30.7) |
Capsular serotypes | |
 K1 | 66 (40.5) |
 K2 | 31 (19.0) |
 K5 | 8 (4.9) |
 K20 | 3 (1.8) |
 non-type | 54 (33.1) |
Virulence genes | |
 aerobactin | 139 (85.3) |
 rmpA | 155 (95.1) |
 iroN | 40 (24.5) |
 kfuBC | 116 (71.2) |
 wcaG | 112 (68.7) |
 ybtA | 120 (73.6) |
 magA | 74 (45.4) |
 fimH | 156 (95.7) |
 mrkD | 163 (100.0) |
 uge | 147 (90.2) |
 entB | 144 (88.3) |
 ureA | 145 (89.0) |
Antimicrobial resistance | |
 Ampicillin | 163 (100.0) |
 Ampicillin/sulbactam | 17 (10.4) |
 Piperacillin/tazobactam | 2 (1.2) |
 Cefazolin | 10 (6.1) |
 Cefotetan | 2 (1.2) |
 Aztreonam | 5 (3.1) |
 Ceftriaxone | 6 (3.7) |
 Ceftazidime | 3 (1.8) |
 Cefepime | 4 (2.5) |
 Cefoperazone/sulbactam | 0 (0.0) |
 Ertapenem | 3 (1.8) |
 Imipenem | 5 (3.1) |
 Ciprofloxacin | 5 (3.1) |
 Levofloxacin | 4 (2.5) |
 Gentamicin | 2 (1.2) |
 Tobramycin | 2 (1.2) |
 Amikacin | 1 (0.6) |
 SMZ-TMP | 6 (3.7) |
 Nitrofurantoin | 34 (20.9) |
MDR strains | 12 (7.4) |
CRKP strains | 6 (3.7) |
Multilocus sequence typing | |
 ST23 | 63 (38.7) |
 ST29 | 10 (6.1) |
 ST65 | 14 (8.6) |
 ST86 | 10 (6.1) |